Suppression of post-transplant arteriosclerosis

Details Suppression of post-transplant arteriosclerosis Suppression of post-transplant arteriosclerosis

2007-12-04

2007-12-04

Crouch, Deborah (Department: 1632)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

Reexamination Certificate

active

10493070

ABSTRACT:
A preventive and/or therapeutic agent for post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening, wherein the agent contains, as an active ingredient, a monocyte chemoattractant protein-1 (MCP-1) function inhibitor. Administration of the MCP-1 function inhibitor enables prevention and treatment of post-transplant arteriosclerosis occurring as a rejection response to organ transplantation or for auto- or allo-arteriovenous graft post-transplant intimal thickening.

REFERENCES:
patent: 5399346 (1995-03-01), Anderson et al.
patent: 5705360 (1998-01-01), Rollins et al.
patent: 5-276986 (1993-10-01), None
patent: 2002-284698 (2002-10-01), None
patent: 96/38559 (1996-12-01), None
Juengst, BMJ Jun. 28, 2003;326(7404):1410-1.
Zhang et al., J Biol Chem. Jun. 3, 1994;269(22):15918-24.
Deonarain, Expert Opin. Ther. Pat, 8: 53-69, 1998.
Chen et al, Transplant immunology, 9: 301-314, 2002.
Romano, Drugs, News Perspect, 16(5): 267-276, 2003.
Thomas et al, Immunological Reviews, 196: 161-175, 2003.
Ogata et al, Cardiology, 101: 144-158, 2004.
Akowuah, et al, Ann Thorac Surg, 76: 959-66, 2003.
Teizo Yoshimura, et al., The Journal of Experimental Medicine, vol. 169, pp. 1449-1459 1989.
Kouji Matsushima, et al., The Journal of Experimental Medicine, vol. 169, pp. 1485-1490 1989.
Teizo Yoshimura, et al., FEBS Letters, vol. 244, No. 2, pp. 487-493 1989.
Israel F. Charo, et al., Proc. Natl. Acad. Sci. USA, vol. 91, pp. 2752-2756 1994.
Shinsuke Yamagami, et al., Biochemical and Biophysical Research Communications, vol. 202, No. 2, pp. 1156-1162 Jul. 29, 1994.
Teizo Yoshimura, et al., The Journal of Immunology, vol. 147, No. 7, pp. 2229-2233 Oct. 1, 1991.
Egashira, Kensuke et al., A novel anti-monocyte chemo-attractant protein-1 gene therapy for atherosclerosis, Japanese Circulation Journal, Mar. 1, 2001, vol. 65, Supplement 1-A, p. 254 (OJ453).
Forsythe, J.L., Graft function and other risk factors as predictors of cardiovascular disease outcome., Transplantation, Sep. 27, 2001, vol. 72, Issue 6 Suppl., S16-9 (abstract) MEDLINE [online]: Retrieved from STN, MEDLINE Accession No. 2001538553.
Zhang, Yu Jun et al., Structure/Activity Analysis of Human Monocyte Chemoattractant Protein-1 (MCP-1) by Mutagenesis, The Journal of Biological Chemistry, Jun. 3, 1994, vol. 269, No. 22, pp. 15918 to 15924.
Egashira, Kensuke et al., Anti-monocyte chemoattractant protein-1 gene therapy inhibits vascular remodeling in rats: blockade of MCP-1 activity after intramuscular transfer of a mutant gene inhibits vascular remodeling induced by chronic blockade of NO synthesis, The FASEB Journal, Oct. 2000, vol. 14, Issue 13, pp. 1974 to 1978.
Kirchengast, Michael et al., Endothelin-1 and Endothelin Receptor Antagonists in Cardiovascular Remodeling, Proceedings of the Society for Experimental Biology and Medicine, Sep. 1999, vol. 221, No. 4, pp. 312-325.
Mitsuaki Isobe et al., “Ishoku Shinkan Domyaku Koka no Shinten Kijo to Yobo—in situ RT-PCR-ho ni yoru Kaiseki to Secchaku Sogal ni yoru Chiryo Koka”, Ono Medical Research Foundation, The 8thAnnual Report 1996 Nendo, Aug. 31, 1997, pp. 67 to 76.

Affiliated with

Also associated with

Rating

Suppression of post-transplant arteriosclerosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Suppression of post-transplant arteriosclerosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Suppression of post-transplant arteriosclerosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3897434